Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker LEN-B
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 4,008 | $79.98 | $320.6K Buy | Form 4 ↗ |
| Sep 30, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 638,813 | $81.59 | $52.1M Buy | Form 4 ↗ |
| Sep 29, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 100 | $80.00 | $8,000 Buy | Form 4 ↗ |
| Sep 29, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 12,289 | $81.95 | $1.0M Buy | Form 4 ↗ |
| Sep 28, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 5,200 | $81.96 | $426.2K Buy | Form 4 ↗ |
| Sep 25, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 7,022 | $79.53 | $558.5K Buy | Form 4 ↗ |
| Sep 25, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 171,723 | $81.60 | $14.0M Buy | Form 4 ↗ |
| Sep 25, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 313,379 | $80.90 | $25.4M Buy | Form 4 ↗ |
| Sep 24, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 2,975 | $79.91 | $237.7K Buy | Form 4 ↗ |
| Sep 24, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 9,415 | $79.42 | $747.7K Buy | Form 4 ↗ |
| Sep 24, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 241,692 | $81.44 | $19.7M Buy | Form 4 ↗ |
| Sep 24, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 399,238 | $80.58 | $32.2M Buy | Form 4 ↗ |
| Sep 23, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 1,263 | $79.99 | $101.0K Buy | Form 4 ↗ |
| Sep 23, 2026 | Warren E. Buffett 10% owner | LEN Lennar Corporation Class A | Buy | 532,993 | $81.65 | $43.5M Buy | Form 4 ↗ |
| Sep 21, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 18,146 | $76.62 | $1.4M Buy | Form 4 ↗ |
| Sep 21, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 4,888 | $75.76 | $370.3K Buy | Form 4 ↗ |
| Sep 21, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 483,809 | $77.97 | $37.7M Buy | Form 4 ↗ |
| Sep 21, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 160,275 | $77.23 | $12.4M Buy | Form 4 ↗ |
| Sep 18, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 500 | $78.38 | $39.2K Buy | Form 4 ↗ |
| Sep 18, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 710 | $76.98 | $54.7K Buy | Form 4 ↗ |
| Sep 18, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 390 | $75.76 | $29.5K Buy | Form 4 ↗ |
| Sep 18, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 33,122 | $74.80 | $2.5M Buy | Form 4 ↗ |
| Sep 18, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 7,900 | $78.88 | $623.2K Buy | Form 4 ↗ |
| Sep 18, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 68,760 | $78.09 | $5.4M Buy | Form 4 ↗ |
| Sep 18, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 51,586 | $77.06 | $4.0M Buy | Form 4 ↗ |
| Sep 18, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 1.22M | $76.39 | $93.1M Buy | Form 4 ↗ |
| Sep 17, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 8,306 | $77.94 | $647.4K Buy | Form 4 ↗ |
| Sep 17, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 8,959 | $76.96 | $689.5K Buy | Form 4 ↗ |
| Sep 17, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 410,164 | $79.41 | $32.6M Buy | Form 4 ↗ |
| Sep 17, 2026 | Berkshire Hathaway Inc 10% owner | LEN, LEN.B Lennar Corporation | Buy | 267,585 | $78.41 | $21.0M Buy | Form 4 ↗ |
| Oct 28, 2024 | Jeffrey Sonnenfeld Director | LEN, LEN.B Lennar Corporation | Sale | 17,500 | $175.13 | $3.1M Sale | Form 4 ↗ |
31 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:32 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances